Literature DB >> 13129651

Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.

Karen Manon Lammers1, Patrizia Brigidi, Beatrice Vitali, Paolo Gionchetti, Fernando Rizzello, Elisabetta Caramelli, Diego Matteuzzi, Massimo Campieri.   

Abstract

A new therapeutic approach for inflammatory bowel diseases is based on the administration of probiotic bacteria. Prokaryotic DNA contains unmethylated CpG motifs which can activate immune responses, but it is unknown whether bacterial DNA is involved in the beneficial effects obtained by probiotic treatment. Peripheral blood mononuclear cells (PBMC) from healthy donors were incubated with pure DNA of eight probiotic strains and with total bacterial DNA from human feces collected before and after probiotic ingestion. Cytokine production was analyzed in culture supernatants. Modification of human microflora after probiotic administration was proven by polymerase chain reaction analysis. Here we show that Bifidobacterium genomic DNA induced secretion of the antiinflammatory interleukin-10 by PBMC. Total bacterial DNA from feces collected after probiotic administration modulated the immune response by a decrease of interleukin-1 beta and an increase of interleukin-10.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129651     DOI: 10.1016/S0928-8244(03)00144-5

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  53 in total

Review 1.  Probiotics in inflammatory bowel disease: is it all gut flora modulation?

Authors:  S Ghosh; D van Heel; R J Playford
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 2.  Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics.

Authors:  Michele Caselli; Giuseppina Vaira; Girolamo Calo; Francesco Papini; John Holton; Dino Vaira
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

3.  Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production.

Authors:  H Dong; I Rowland; K M Tuohy; L V Thomas; P Yaqoob
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

4.  Cross species expression analysis of innate immune response.

Authors:  Yong Lu; Roni Rosenfeld; Gerard J Nau; Ziv Bar-Joseph
Journal:  J Comput Biol       Date:  2010-03       Impact factor: 1.479

Review 5.  Probiotics and barrier function in colitis.

Authors:  P Gionchetti; K M Lammers; F Rizzello; M Campieri
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

6.  Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota.

Authors:  You Jin Jang; Woon-Ki Kim; Dae Hee Han; Kiuk Lee; Gwangpyo Ko
Journal:  Gut Microbes       Date:  2019-04-03

7.  Tapioca Starch Modulates Cellular Events in Oral Probiotic Streptococcus salivarius Strains.

Authors:  Rafig Gurbanov; Hazel Karadağ; Sevinç Karaçam; Gizem Samgane
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

8.  The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept).

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  Genes Nutr       Date:  2011-04-16       Impact factor: 5.523

9.  Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications.

Authors:  M Medina; E Izquierdo; S Ennahar; Y Sanz
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

10.  Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients.

Authors:  Marcela Medina; Giada De Palma; Carmen Ribes-Koninckx; Miguel Calabuig; Yolanda Sanz
Journal:  J Inflamm (Lond)       Date:  2008-11-03       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.